CTSO
Cytosorbents Corp

2,146
Mkt Cap
$40.12M
Volume
157,938.00
52W High
$1.61
52W Low
$0.60
PE Ratio
-3.36
CTSO Fundamentals
Price
$0.6222
Prev Close
$0.6388
Open
$0.6515
50D MA
$0.8507
Beta
0.77
Avg. Volume
75,799.52
EPS (Annual)
-$0.3806
P/B
4.45
Rev/Employee
$238,889.40
Loading...
Loading...
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
149

Frequently Asked Questions

What is Market Cap of Cytosorbents Corp?
What is the 52-week high for Cytosorbents Corp?
What is the 52-week low for Cytosorbents Corp?
What is Cytosorbents Corp stock price today?
What was Cytosorbents Corp stock price yesterday?
What is the PE ratio of Cytosorbents Corp?
What is the Price-to-Book ratio of Cytosorbents Corp?
What is the 50-day moving average of Cytosorbents Corp?
How many employess does Cytosorbents Corp has?

Latest CTSO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.